Healthcare antitrust, settlements, and the Federal Trade Commission
著者
書誌事項
Healthcare antitrust, settlements, and the Federal Trade Commission
(Research in law and economics / editor, Richard O. Zerbe, Jr, v. 28)
Emerald, 2018
大学図書館所蔵 全7件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission ("FTC"). Four of the articles were initially presented at a conference on healthcare competition in Washington, D.C., which was sponsored by the American Antitrust Institute, this journal, and Navigant Economics. These articles explore practices that are under challenge in pharmaceuticals, where the Federal Trade Commission has been extremely active, as well as issues involving hospital and health insurance mergers. They are followed by a long and detailed discussion of the current and historic role of economists and economic analysis at the Federal Trade Commission. The next two articles analyze different aspects of the French economy, pre-trial labor settlements and the impact of e-commerce on franchisees. The volume ends with three technical economics articles - one on "upward pricing pressure", one on estimating price increases in cartel cases, and one critiquing a "meta-analysis" of research on the effectiveness of U.S. merger regulation. Taken together, these articles raise questions about appropriate competition policy, how to evaluate settlements and other firm behavior, and where economics and competition policy are headed.
目次
- IntroductionChapter 1. "TO KNOW WHERE YOU'RE GOING, LOOK AT WHERE YOU'VE BEEN"
- Deborah L. Feinstein Chapter 2. ACTAVIS, AUTHORIZED GENERICS, AND THE FUTURE OF ANTITRUST LAW
- Marc G. Schildkraut Chapter 3. SOLVING THE PRODUCT HOPPING CONUNDRUM THROUGH SAFE HARBORS AND A NO-ECONOMIC-SENSE TEST
- Michael A. Carrier and Steve D. Shadowen Chapter 4. A MARKET ALL ITS OWN: MEDICARE ADVANTAGE AS A SEPARATE PRODUCT MARKET IN THE DOJ'S CASE AGAINST THE AETNA-HUMANA MERGER
- Douglas Ross and David Maas Chapter 5. A HISTORY OF THE FTC'S BUREAU OF ECONOMICS
- Paul A. Pautler Chapter 6. LABOR DISPUTES AND PRETRIAL SETTLEMENTS: THE FRENCH CASE
- Jean-Christian Tisserand Chapter 7. FRANCHISEES FACING ONLINE SALES IN A EUROPEAN LEGAL CONTEXT
- Guy Basset, Rozenn Perrigot, and Gerard Cliquet Chapter 8. MANDATORY UPSTREAM INPUTS AND UPWARD PRICING PRESSURE: IMPLICATIONS FOR COMPETITION POLICY
- Timothy J. Tardiff and Dennis L. Weisman Chapter 9. WHEN IS THE "KENNEDY CORRECTION" APPROPRIATE IN ESTIMATING OVERCHARGES?
- Wenqing Li and James F. Nieberding Chapter 10. KWOKA'S MERGERS, MERGER CONTROL, AND REMEDIES: REJOINDER TO KWOKA
- Michael Vita
「Nielsen BookData」 より